Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 235 Yorkland Blvd Suite 900 TORONTO ON M2J 4Y8 |
Tel: | N/A |
Website: | https://www.venusconcept.com/en-uk |
IR: | See website |
Key People | ||
Hemanth Varghese President, Chief Operating Officer | Rajiv De Silva Chief Executive Officer, Director | Domenic Della Penna Chief Financial Officer, Executive Vice President |
Anna Georgiadis Chief Human Resource Officer | Ross J. Portaro Executive Vice President and General Manager - Global Sales & Marketing | William H. Mcgrail Senior Vice President - Technical Operations and Compliance | Michael Mandarello General Counsel, Corporate Secretary |
Business Overview |
Venus Concept Inc. is a global medical aesthetic technology company. The Company has a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches in over 60 countries and 14 direct markets. The Company's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. The Company's systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company's hair loss treatment solutions include the ARTAS Solution and the NeoGraft Solution. |
Financial Overview |
For the nine months ended 30 September 2023, Venus Concept Inc revenues decreased 23% to $58.2M. Net loss decreased 23% to $26.1M. Revenues reflect Subscription'��Systems segment decrease of 51% to $14.4M, Products'��Other segment decrease of 17% to $8M, International segment decrease of 28% to $26.6M, United States segment decrease of 17% to $31.7M. |
Employees: | 384 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $78.70M as of Sep 30, 2023 |
Annual revenue (TTM): | $82.51M as of Sep 30, 2023 |
EBITDA (TTM): | -$23.81M as of Sep 30, 2023 |
Net annual income (TTM): | -$36.05M as of Sep 30, 2023 |
Free cash flow (TTM): | -$15.62M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $74.12M as of Sep 30, 2023 |
Shares outstanding: | 6,355,230 as of Feb 22, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |